Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

NCT06285539 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Behcet's Disease
Idiopathic Inflammatory Myopathies
IgG4-related Disease

Interventions

DRUG: Filgotinib

Sponsor

UMC Utrecht

Collaborators

[object Object]
[object Object]
[object Object]